Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Navdeep S Lail"'
Autor:
Haris Kamal, Muhammad K Ahmed, Alicia Zha, Navdeep S Lail, Peyman Shirani, Robert N Sawyer, Ashkan Mowla
Publikováno v:
Brain Circulation, Vol 6, Iss 3, Pp 196-199 (2020)
BACKGROUND: Studies have shown that 4%–17% of acute ischemic strokes (AISs) occur in patients hospitalized for another reason; scanty data are available about the care delivery and outcome of this patient population. MATERIALS AND METHODS: All cons
Externí odkaz:
https://doaj.org/article/f3dcc263f17c4e7780cdd8d72ef90391
Autor:
Ashkan Mowla, Navdeep S. Lail, Maria Daniela Zambrano Espinoza, Caila B. Vaughn, Peyman Shirani, Robert N. Sawyer
Publikováno v:
Cerebrovascular Diseases. 50:141-146
Background: We sought to investigate the effect of obesity and BMI on functional outcome and rate of symptomatic intracranial hemorrhage (sICH) in a large sample of patients with acute ischemic stroke (AIS) treated with intravenous thrombolysis (IVT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bced80fa8aa872b72a4474b1682f3bf0
https://doi.org/10.1159/000511489
https://doi.org/10.1159/000511489
Autor:
Haris Kamal, Katelyn Kavak, Pegah Mohammadi, Navdeep S. Lail, Robert N. Sawyer, Seyed Mostafa Razavi, Ashkan Mowla, Peyman Shirani
Publikováno v:
Journal of the neurological sciences. 429
Background and purpose Combining intra-arterial mechanical thrombectomy (IAMT) and intravenous thrombolysis (IVT) has shown to have an excellent recanalization rate and better clinical outcome in acute ischemic stroke (AIS) patients. Hyperdense middl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d840448979f0a1f00268799de5856a4
https://pubmed.ncbi.nlm.nih.gov/34418800
https://pubmed.ncbi.nlm.nih.gov/34418800
Autor:
Alicia Zha, Bijal Mehta, Muhammad K. Ahmed, Fawaz Al-Mufti, Peyman Shirani, Robert N. Sawyer, Katelyn Kavak, Haris Kamal, Navdeep S. Lail, Ashkan Mowla
Publikováno v:
Journal of the neurological sciences. 420
Laboratory factors associated with hemorrhagic conversion (HC) after Intravenous thrombolysis with rtPA (IVT) for Acute Ischemic Stroke (AIS) remain nebulous despite advances in our knowledge of AIS. This study aimed to investigate the laboratory fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5e7ebc52e5655eb7a62d14dce17b2e6
https://pubmed.ncbi.nlm.nih.gov/33333324
https://pubmed.ncbi.nlm.nih.gov/33333324
Autor:
Harshit Shah, Robert N. Sawyer, Peyman Shirani, Caila B. Vaughn, Navdeep S. Lail, Ashkan Mowla
Publikováno v:
Cerebrovascular diseases (Basel, Switzerland). 49(5)
Aim: The aim of this was to study the effects of statins and their intensity on symptomatic intracranial hemorrhage (sICH) and outcome after IV thrombolysis (IVT) for acute ischemic stroke (AIS). Methods: We retrospectively reviewed the medical recor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f30da2985111ec104a34b5403fca484
https://pubmed.ncbi.nlm.nih.gov/32927457
https://pubmed.ncbi.nlm.nih.gov/32927457
Autor:
Ashkan Mowla, Haris Kamal, Caila B. Vaughn, Robert N. Sawyer, Marilou Ching, Hamidreza Rajabzadeh-Oghaz, Sandhya Mehla, Annemarie Crumlish, Peyman Shirani, Christopher Deline, Navdeep S. Lail
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 26:1414-1418
Objective To determine the safety of intravenous (IV) recombinant tissue plasminogen activator (rtPA) in patients with acute ischemic stroke (AIS) who had a platelet count Methods We reviewed the charts of all patients who received IV rtPA for AIS du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d0376f1ddebc6bee2c686fc1abdb33
https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.03.021
https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.03.021
Autor:
Robert N. Sawyer, Amirhossein Sharifian-Dorche, Maryam Sharifian-Dorche, Ashkan Mowla, Caila B. Vaughn, Sandhya Mehla, Navdeep S. Lail, Peyman Shirani
Publikováno v:
Journal of the Neurological Sciences. 425:117451
Aim To study the effects of pretreatment with Antiplatelet (AP) before IV thrombolysis (IVT) on the rate of symptomatic intracranial hemorrhage (sICH) and functional outcome in patients with Acute Ischemic stroke (AIS). Method In this retrospective s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38735da8030feb7ca80031041f94dd58
https://doi.org/10.1016/j.jns.2021.117451
https://doi.org/10.1016/j.jns.2021.117451
Autor:
Robert N. Sawyer, Seyed-Mostafa Razavi, Ashkan Mowla, Aurangzeb Memon, Navdeep S. Lail, Peyman Shirani, Caila B. Vaughn, Pegah Mohammadi
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 30:105678
Current guidelines allow the administration of intravenous recombinant tissue plasminogen activator (IV r-tPA) to warfarin-treated patients with acute ischemic stroke (AIS) who have an international normalized ratio (INR) of ≤1.7. However, concerns
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a885fbcdaad4d65e471605fef2ee473
https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105678
https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105678
Autor:
Navdeep S. Lail, Peyman Shirani, Alicia Zha, Muhammad K. Ahmed, Robert N. Sawyer, Ashkan Mowla, Haris Kamal
Publikováno v:
Brain Circulation, Vol 6, Iss 3, Pp 196-199 (2020)
Brain Circulation
Brain Circulation
BACKGROUND: Studies have shown that 4%–17% of acute ischemic strokes (AISs) occur in patients hospitalized for another reason; scanty data are available about the care delivery and outcome of this patient population. MATERIALS AND METHODS: All cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f0b95f0276e6982309d41d2392165cd
https://doi.org/10.4103/bc.bc_24_20
https://doi.org/10.4103/bc.bc_24_20
Autor:
Haris Kamal, Robert N. Sawyer, Christopher Deline, Navdeep S. Lail, Caila B. Vaughn, Ashkan Mowla
Publikováno v:
Archives of Neuroscience.
We present 3 patients who were taking oral direct factor Xa inhibitors (ODFXIs) within 24 hours prior to receiving intravenous recombinant tissue plasminogen activator (IV rtPA) for acute ischemic stroke (AIS). Two patients were on Rivaroxaban (20 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34bed9cc6e454ce3e3882ca5c2ff7d52
https://doi.org/10.5812/ans.67359
https://doi.org/10.5812/ans.67359